Global Pharmaceutical Policy
Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality ‘research-based information’ in this field
- PDF / 4,870,029 Bytes
- 376 Pages / 433.76 x 612.28 pts Page_size
- 99 Downloads / 225 Views
Global Pharmaceutical Policy
Zaheer-Ud-Din Babar Editor
Global Pharmaceutical Policy
Editor Zaheer-Ud-Din Babar Centre for Pharmaceutical Policy and Practice Research University of Huddersfield Huddersfield, UK
ISBN 978-981-15-2723-4 ISBN 978-981-15-2724-1 (eBook) https://doi.org/10.1007/978-981-15-2724-1 © The Editor(s) (if applicable) and The Author(s) 2020 This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Cover illustration: © imageBROKER / Alamy Stock Photo This Palgrave Macmillan imprint is published by the registered company Springer Nature Singapore Pte Ltd. The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore
To Danyal
Preface
The pharmaceutical policy deals with access to safe, effective and “quality use of medicines”. Around the globe, there are challenges in regard to access to innovative treatments and the affordability of expensive medicines. Also, “access to high-cost medicines”, “innovative biologicals and vaccines” and the “issues related to medicines access, trade, and intellectual property rights” are central to any pharmaceutical policy. However, dealing with these issues and forming effective pharmaceutical policies has played a central role in improving access to medicines. The pandemics like COVID-19 have again put a major emphasis on the need for newer innovative treatments and the availability of affordable vaccines. The national pharmaceutical policies have been effective in eradicating diseases and in improving patients’ quality of life. However, forming these policies is a complex challenge and requires a number of capacity-building measures including good governance and legislation, trained workforce and human expertise as well as a viable local pharmaceutical industry. This book documents a number of pharmaceutical policy issues in the form of sy
Data Loading...
